At the heart of our organization lies a personal journey and a mission to revolutionize brain health. When faced with the challenges of cognitive decline within our own circle, we embarked on a quest to find a solution that was both effective and accessible.
Groundbreaking, science-backed 40Hz light therapy showcases the potential to rejuvenate brain functions, reduce toxic amyloid plaque build-up, and significantly improve neural connectivity.
With a vision to bring this transformative therapy to homes worldwide, BEACON40 smart lamps were born. Our smart lamp technology, designed with precision, offers an effortless way to integrate 40Hz light therapy into daily routines. It’s not just about lighting up a room; it’s about illuminating a path to better cognitive health, improved sleep, and overall well-being.
Scientifically Proven: Our technology is rooted in rigorous scientific research, ensuring you receive the best light therapy.
Doctor-Recommended: Medical professionals endorse BEACON40 for its potential to enhance brain health and sleep quality. Research continues to show memory and sleep are intimately and interdependently related.
Effortless Integration: Designed to blend seamlessly into your daily life, BEACON40 offers a hassle-free approach to cognitive wellness. We take advancing scientific research out of the lab and into your home.
Safety First: Our commitment to your well-being ensures that BEACON40 is non-invasive, safe, and available without a prescription.
As we continue our journey, our task remains clear: to make the transformative power of 40Hz light therapy accessible to all. We invite you to join us in this mission and experience the BEACON40 difference.
Each dedicated member of our team is fervently committed to harnessing the latest scientific breakthroughs for you. Our goal is to enhance and prolong your well-being and vitality, placing paramount importance on brain health.
At the heart of our organization lies a personal journey and a mission to revolutionize brain health. When faced with the challenges of cognitive decline within our own circle, we embarked on a quest to find a solution that was both effective and accessible.
Groundbreaking, science-backed 40Hz light therapy showcases the potential to rejuvenate brain functions, reduce toxic amyloid plaque build-up, and significantly improve neural connectivity.
With a vision to bring this transformative therapy to homes worldwide, BEACON40 smart lamps were born. Our smart lamp technology, designed with precision, offers an effortless way to integrate 40Hz light therapy into daily routines. It’s not just about lighting up a room; it’s about illuminating a path to better cognitive health, improved sleep, and overall well-being.
Scientifically Proven: Our technology is rooted in rigorous scientific research, ensuring you receive the best light therapy.
Doctor-Recommended: Medical professionals endorse BEACON40 for its potential to enhance brain health and sleep quality. Research continues to show memory and sleep are intimately and interdependently related.
Effortless Integration: Designed to blend seamlessly into your daily life, BEACON40 offers a hassle-free approach to cognitive wellness. We take advancing scientific research out of the lab and into your home.
Safety First: Our commitment to your well-being ensures that BEACON40 is non-invasive, safe, and available without a prescription.
As we continue our journey, our task remains clear: to make the transformative power of 40Hz light therapy accessible to all. We invite you to join us in this mission and experience the BEACON40 difference.
Groundbreaking, science-backed 40Hz light therapy showcases the potential to rejuvenate brain functions, reduce toxic amyloid plaque build-up, and significantly improve neural connectivity.
With a vision to bring this transformative therapy to homes worldwide, BEACON40 smart lamps were born. Our smart lamp technology, designed with precision, offers an effortless way to integrate 40Hz light therapy into daily routines. It’s not just about lighting up a room; it’s about illuminating a path to better cognitive health, improved sleep, and overall well-being.
As Chief Knowledge Officer, Veronica Price oversees knowledge management for BRIGHT ensuring that the company effectively leverages current and emerging research and resources. Veronica also shares the company’s motivation to battle cognitive decline as a caregiver of a loved one with Alzheimer’s disease.
Veronica brings to BRIGHT an education in neurobiology and 20+ years of diverse business experience in start-ups, corporations, and nonprofits. Prior to BRIGHT, Veronica has focused on entrepreneur training, program pilots, and developing new markets, as well as advising organizations on innovation strategy. A serial entrepreneur in her own right, Veronica ran a successful business for more than 10 years.
Veronica holds a Bachelor’s of Science from Binghamton University focusing on the biology of behavior, perception, and memory.
Laura Sanders is an experienced global startup advisor. Having held roles from CFO to COO and Business Development, she has spent the last 20 years supporting and growing technology and media startups on the west coast.
Laura began her career as an investment banker at UBS and Citigroup in New York focusing on the industrials, media and gaming sectors.
She received an M.B.A. in Finance and Management from NYU’s Stern School of business and earned a B.S. in Accounting from Lehigh University.
She has also held a Top-Secret security clearance from the US Department of Defense.
As Senior Vice President of Business Development, Thalia Taylor brings her expertise and a passion for fast-tracking public access to cutting-edge scientific solutions. Her experience of losing her mother to early-onset dementia fortifies her commitment to finding ways to increase longevity and enhance quality of life for millions of people through advances in science and technology.
As an award-winning healthcare management and business development consultant and entrepreneur, Thalia has a reputation for founding, leading, and advising companies that perform pioneering research in high-throughput, state-of-the-art, dynamic work environments. She has spent the last 15 years growing clinical labs, biotechnology, and healthcare startups in the Research Triangle Park of North Carolina with a focus on supporting female-owned businesses.
Thalia began her career with the human genome sequencing project, spent a decade in drug discovery at GSK, worked as a CLIA auditor for the state of North Carolina, and continues to consult on projects with leading pharmaceutical and healthcare companies. She serves on the board of Integrated Laboratory Systems.
Thalia is a published author who holds degrees in Biology and Biopharmaceutical Technology. She did her graduate and undergraduate studies at the University of North Carolina at Chapel Hill. She is the recipient of the Cisco Systems Growing with Technology Award (Innovators in Customer Relationship category), the COLA Laboratory Excellence Award, and the Best of Durham, City of Medicine, Award for Best Independent Reference Lab.
Kim brings nearly two decades of expertise in developing and implementing strategic marketing campaigns that support revenue growth. Her background includes heading operations at the agency level as well as directing hyper-focused expansion across an array of marketing channels. Kim’s analytical prowess drives our strategic planning by analyzing trend data and customer engagement.
As head of demand generation, Kim leads BRIGHT’s digital engagement from education to purchase. Her passion for delivering information through contextual search and applicable content has helped BRIGHT advance its ongoing mission of hope and help.
The mother of three grown children, Kim also cares for her aging parents, like so many in the “sandwiched” generation.
Ale is placed at a unique intersection of operations, marketing, project management, and creativity. She has worked with tech, wellness, and fashion startups as well as established advertising companies including McCann Erickson and Foote, Cone & Belding. Ale brings this diverse experience as well as grit and an obsession with execution to her role as Director of Operations of BRIGHT. Ale’s work in advertising has earned her a Cannes Lions award for campaign effectiveness. She holds an MBA from Vilnius Tech University. She is passionate about photography and enjoys learning about non-invasive holistic treatments.
Liza has more than 10 years experience as a strategic capital decision-maker for leading investment managers and global corporations.
Before joining BRIGHT, Liza was an investment analyst at foundations and endowments including Trinity Church, SUNY Stony Brook, and The Juilliard School. Prior to that, she managed a $100M+ strategic investment portfolio at Amex. Liza began her career as a corporate loan officer at Raiffeisenbank.
Liza holds an MBA from Fordham University, with a concentration in finance and accounting. She is passionate about helping disadvantaged groups find empowerment through economic opportunity and has mentored immigrant-owned businesses as a volunteer for Net Impact.
As Chief Knowledge Officer, Veronica Price oversees knowledge management for BRIGHT ensuring that the company effectively leverages current and emerging research and resources. Veronica also shares the company’s motivation to battle cognitive decline as a caregiver of a loved one with Alzheimer’s disease.
Veronica brings to BRIGHT an education in neurobiology and 20+ years of diverse business experience in start-ups, corporations, and nonprofits. Prior to BRIGHT, Veronica has focused on entrepreneur training, program pilots, and developing new markets, as well as advising organizations on innovation strategy. A serial entrepreneur in her own right, Veronica ran a successful business for more than 10 years.
Veronica holds a Bachelor’s of Science from Binghamton University focusing on the biology of behavior, perception, and memory.
Laura Sanders is an experienced global startup advisor. Having held roles from CFO to COO and Business Development, she has spent the last 20 years supporting and growing technology and media startups on the west coast.
Laura began her career as an investment banker at UBS and Citigroup in New York focusing on the industrials, media and gaming sectors.
She received an M.B.A. in Finance and Management from NYU’s Stern School of business and earned a B.S. in Accounting from Lehigh University.
She has also held a Top-Secret security clearance from the US Department of Defense.
As Senior Vice President of Business Development, Thalia Taylor brings her expertise and a passion for fast-tracking public access to cutting-edge scientific solutions. Her experience of losing her mother to early-onset dementia fortifies her commitment to finding ways to increase longevity and enhance quality of life for millions of people through advances in science and technology.
As an award-winning healthcare management and business development consultant and entrepreneur, Thalia has a reputation for founding, leading, and advising companies that perform pioneering research in high-throughput, state-of-the-art, dynamic work environments. She has spent the last 15 years growing clinical labs, biotechnology, and healthcare startups in the Research Triangle Park of North Carolina with a focus on supporting female-owned businesses.
Thalia began her career with the human genome sequencing project, spent a decade in drug discovery at GSK, worked as a CLIA auditor for the state of North Carolina, and continues to consult on projects with leading pharmaceutical and healthcare companies. She serves on the board of Integrated Laboratory Systems.
Thalia is a published author who holds degrees in Biology and Biopharmaceutical Technology. She did her graduate and undergraduate studies at the University of North Carolina at Chapel Hill. She is the recipient of the Cisco Systems Growing with Technology Award (Innovators in Customer Relationship category), the COLA Laboratory Excellence Award, and the Best of Durham, City of Medicine, Award for Best Independent Reference Lab.
Kim brings nearly two decades of expertise in developing and implementing strategic marketing campaigns that support revenue growth. Her background includes heading operations at the agency level as well as directing hyper-focused expansion across an array of marketing channels. Kim’s analytical prowess drives our strategic planning by analyzing trend data and customer engagement.
As head of demand generation, Kim leads BRIGHT’s digital engagement from education to purchase. Her passion for delivering information through contextual search and applicable content has helped BRIGHT advance its ongoing mission of hope and help.
The mother of three grown children, Kim also cares for her aging parents, like so many in the “sandwiched” generation.
Liza has more than 10 years experience as a strategic capital decision-maker for leading investment managers and global corporations.
Before joining BRIGHT, Liza was an investment analyst at foundations and endowments including Trinity Church, SUNY Stony Brook, and The Juilliard School. Prior to that, she managed a $100M+ strategic investment portfolio at Amex. Liza began her career as a corporate loan officer at Raiffeisenbank.
Liza holds an MBA from Fordham University, with a concentration in finance and accounting. She is passionate about helping disadvantaged groups find empowerment through economic opportunity and has mentored immigrant-owned businesses as a volunteer for Net Impact.
Dr. Baxter is Founder and CEO of MMJ Labs Pain Relief, whose missions are to eliminate unnecessary pain and uncouple pain from fear. She invented VibraCool® to treat tendinitis and decrease opioid use, and her Buzzy® device has been used by over a quarter million people to control needle pain.
As a double boarded pediatric emergency physician, Dr. Baxter founded and directed PEMA Emergency Research, Scottish Rite, Children’s Healthcare of Atlanta. After graduating from Yale University and Emory University School of Medicine, she completed a pediatrics residency, child abuse fellowship, and emergency pediatrics fellowship. Dr. Baxter is known for creating and validating the BARF nausea scale for children with cancer, and holds patents on FDA 510K cleared MDEA-Winning Buzzy® physiologic pain blocker, VibraCool® Massaging Ice Therapy and DistrACTION® cards.
National speaking venues include Exponential Medicine, AARP Life at 50+, and TEDMED. She has been named a 2017 Healthcare Transformer, Wall Street Journal “Idea Person”, Most Innovative CEO of the Year by GA Bio, a Top 10 Disruptors in Medical Tech, and “Top Women in Tech to Watch” by Inc.
As BRIGHT’s Co-Founder, former COO, and advisor, Irina Tanenbaum is driven personally and professionally by the BRIGHT mission. Irina helped establish the health and technology company with the same ambition to join in the battle against cognitive decline and bring hope to families struggling with Alzheimer’s disease and other dementias.
Prior to joining BRIGHT, Irina spent 15 years
leading investment research and due
diligence for institutional investors. Irina was responsible for investment and operational due diligence at a FinTech startup, which propelled her into the world of
entrepreneurship. Irina founded her own consulting firm, cultivating growth for seed-stage companies. Irina has worked with
FinTech, MedTech, life sciences, consumer,
and social media companies.
Irina holds a BS in finance from Rutgers
University School of Business and an MBA
from the Stern School of Business, New York
University. She is passionate about providing
education and growth opportunities to low income communities and has volunteered for
iMentor and Upwardly Global.
Dr. Baxter is Founder and CEO of MMJ Labs Pain Relief, whose missions are to eliminate unnecessary pain and uncouple pain from fear. She invented VibraCool® to treat tendinitis and decrease opioid use, and her Buzzy® device has been used by over a quarter million people to control needle pain.
As a double boarded pediatric emergency physician, Dr. Baxter founded and directed PEMA Emergency Research, Scottish Rite, Children’s Healthcare of Atlanta. After graduating from Yale University and Emory University School of Medicine, she completed a pediatrics residency, child abuse fellowship, and emergency pediatrics fellowship. Dr. Baxter is known for creating and validating the BARF nausea scale for children with cancer, and holds patents on FDA 510K cleared MDEA-Winning Buzzy® physiologic pain blocker, VibraCool® Massaging Ice Therapy and DistrACTION® cards.
National speaking venues include Exponential Medicine, AARP Life at 50+, and TEDMED. She has been named a 2017 Healthcare Transformer, Wall Street Journal “Idea Person”, Most Innovative CEO of the Year by GA Bio, a Top 10 Disruptors in Medical Tech, and “Top Women in Tech to Watch” by Inc.
Dr. Jack Keene has over 30 years of entrepreneurial experience and physician leadership. He co-founded Emergency Treatment Associates which revolutionized emergency department care in the Hudson Valley of New York.
A national expert on emergency department management, he and his team introduced modern triage, sophisticated quality management, risk management, bedside registration and the first emergency department electronic medical record north of New York City. His customer satisfaction program led to rave reviews.
Dr. Keene has years of strategic planning experience with a deep understanding of healthcare regulations, medical devices, fitness, wellness, rural healthcare and home healthcare needs. His knowledge of medicine as a science and healthcare as a business provides a valuable perspective to established businesses and start-up companies alike.
Dr. Signaevsky’s research interests in Neuroscience focus on developing an Artificial Intelligence/Machine Learning platform for diagnosis and quantification of neurodegenerative disease as well as developing an interface between the brain, its neural network, and computing devices.
Dr. Signaevsky has received his medical (MD) and research (Ph.D.) training in Russia and The Netherlands and moved to North America to pursue his life-long goals of solving fundamental medical problems. His first foray into the clinical research involved exploratory projects in cancer research, which led to a series of papers and patents. Later, Dr. Signaevsky successfully completed a five-year neuropathology residency at the University of British Columbia. It was followed by a fellowship in neurodegenerative diseases, and subsequently, by a fellowship in Brain Banking at the Icahn School of Medicine at Mount Sinai in New York, NY.
Dr. Signaevsky is also a recipient of a NIH/NIA Career Development in the Neuropathology of AD Award. He has co-founded NeuroSilica, Inc. in 2015, to lead the R&D of brain-computer interface.
BEACON40® is a doctor-recommended light therapy that rejuvenates brain function leading to remarkable health benefits.
FOR SMALL SPACES
To suit individual needs; ideal for those who prefer to spend time in the same place each day. Set up right where you need it most.
FOR LARGE SPACES
FOR SHARED SPACES
